W

ASHINGTON — Fifty congressional Democrats signed on to a letter advancing the pharmaceutical industry’s talking points — and now a drug pricing advocacy group is calling them out.

Patients for Affordable Drugs sent a letter this morning to Speaker Paul Ryan and House Minority Leader Nancy Pelosi, along with the 50 Democrats, condemning the members who signed on to a separate May 24 missive that supports one of the drug industry’s chief lobbying priorities: a change to their financial liability in the so-called “donut hole.”

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy